SPH Phililab signed an agreement with SPH Shanghai Zhongxi Pharmaceutical Co. Ltd., for the development, FDA registration, and US marketing of a generic oral suspension product.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt